Literature DB >> 4038713

Pituitary-testicular axis dysfunction in burned men.

A V Vogel, G T Peake, R T Rada.   

Abstract

Plasma total testosterone, free testosterone, LH, and sex hormone-binding globulin (testosterone-estradiol-binding globulin) were measured in adult men hospitalized for treatment of burns. Total testosterone was below the normal range in 37 of 41 patients. Free and total testosterone levels declined very rapidly after the burn, remained low for weeks, and rose toward the end of hospitalization, but usually had not reached normal levels at discharge. The more severe the burns, the lower were the testosterone levels. LH levels were below normal during the first 4 days after the burn and remained in the low or mid normal range thereafter. Sex hormone-binding globulin levels were normal or slightly low. The data suggest the presence of a central defect in the release of LH. Large doses of opiate analgesics or an increase in endogenous opiate peptides related to severe persistent pain might be contributing factors to the pituitary-testicular hypofunction found in burned men.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4038713     DOI: 10.1210/jcem-60-4-658

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  10 in total

1.  TNF-α-mediated suppression of Leydig cell steroidogenesis involves DAX-1.

Authors:  Mohanraj Sadasivam; Balamurugan Ramatchandirin; Sivasangari Balakrishnan; Chidambaram Prahalathan
Journal:  Inflamm Res       Date:  2015-06-06       Impact factor: 4.575

2.  Mechanisms leading to hypogonadism in men with burns injuries.

Authors:  C G Semple; W R Robertson; R Mitchell; D Gordon; C E Gray; G H Beastall; W H Reid
Journal:  Br Med J (Clin Res Ed)       Date:  1987-08-15

3.  Testosterone levels increase in association with recovery from acute fracture in men.

Authors:  A S Cheung; S Baqar; R Sia; R Hoermann; S Iuliano-Burns; T D T Vu; C Chiang; E J Hamilton; E Gianatti; E Seeman; J D Zajac; M Grossmann
Journal:  Osteoporos Int       Date:  2014-05-07       Impact factor: 4.507

4.  HDAC7 modulates TNF-α-mediated suppression of Leydig cell steroidogenesis.

Authors:  Mohanraj Sadasivam; Balamurugan Ramatchandirin; Sivasangari Balakrishnan; Chidambaram Prahalathan
Journal:  Mol Cell Biochem       Date:  2015-04-28       Impact factor: 3.396

5.  Tumor necrosis factor alpha (TNF) suppresses cAMP response element (CRE) activity and nuclear CRE binding protein in MA-10 mouse Leydig tumor cells.

Authors:  Koji Y Arai; Katherine F Roby; Paul F Terranova
Journal:  Endocrine       Date:  2005-06       Impact factor: 3.633

6.  Gonadal status and body mass index jointly determine growth hormone (GH)-releasing hormone/GH-releasing peptide synergy in healthy men.

Authors:  Remberto C Paulo; Mihaela Cosma; Cacia Soares-Welch; Joy N Bailey; Kristi L Mielke; John M Miles; Cyril Y Bowers; Johannes D Veldhuis
Journal:  J Clin Endocrinol Metab       Date:  2007-12-11       Impact factor: 5.958

Review 7.  Cytokines and reproduction.

Authors:  C Simón; M L Polan
Journal:  West J Med       Date:  1994-05

8.  Molecular mechanism of suppression of testicular steroidogenesis by proinflammatory cytokine tumor necrosis factor alpha.

Authors:  Cheol Yi Hong; Jin Hee Park; Ryun Seop Ahn; Suhn Young Im; Hueng-Sik Choi; Jaemog Soh; Synthia H Mellon; Keesook Lee
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

9.  Mapping the Steroid Response to Major Trauma From Injury to Recovery: A Prospective Cohort Study.

Authors:  Mark A Foster; Angela E Taylor; Neil E Hill; Conor Bentley; Jon Bishop; Lorna C Gilligan; Fozia Shaheen; Julian F Bion; Joanne L Fallowfield; David R Woods; Irina Bancos; Mark M Midwinter; Janet M Lord; Wiebke Arlt
Journal:  J Clin Endocrinol Metab       Date:  2020-03-01       Impact factor: 5.958

10.  An unusual prostate-specific antigen decrease in an advanced castration-resistant prostate cancer patient with intracerebral hemorrhage subsequently treated with luteinizing hormone-releasing hormone antagonist.

Authors:  Kouji Izumi; Atsushi Mizokami; Mikio Namiki
Journal:  Case Rep Nephrol Urol       Date:  2013-12-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.